Similar articles

• Individual patients' data meta-analyses in head and neck cancer.

  Bourhis J, Le Maître A, Baujat B, Audry H, Pignon JP; Meta-Analysis of Chemotherapy in Head, Neck Cancer Collaborative Group; Meta-Analysis of Radiotherapy in Carcinoma of Head, Neck Collaborative Group; Meta-Analysis of Chemotherapy in Nasopharynx Carcinoma Collaborative Group. Bourhis J, et al. Curr Opin Oncol. 2007 May;19(3):188-94. doi: 10.1097/CCO.0b013e3280f01010. Curr Opin Oncol. 2007. PMID: 17414635 Review.
• Neoadjuvant chemotherapy of cisplatin and fluorouracil regimen in head and neck squamous cell carcinoma: a meta-analysis.

  Su YX, Zheng JW, Zheng GS, Liao GQ, Zhang ZY. Su YX, et al. Chin Med J (Engl). 2008 Oct 5;121(19):1939-44. Chin Med J (Engl). 2008. PMID: 19080128
• Chemotherapy of head and neck cancer.

  LaFollette S, Taylor SG 4th. LaFollette S, et al. Cancer Chemother Biol Response Modif. 1996;16:462-73. Cancer Chemother Biol Response Modif. 1996. PMID: 8639394 Review. No abstract available.
• Random effects survival models gave a better understanding of heterogeneity in individual patient data meta-analyses.

  Michiels S, Baujat B, Mahé C, Sargent DJ, Pignon JP. Michiels S, et al. J Clin Epidemiol. 2005 Mar;58(3):238-45. doi: 10.1016/j.jclinepi.2004.08.013. J Clin Epidemiol. 2005. PMID: 15718112
• [The present situation of neoadjuvant therapy for head and neck carcinoma].

  Rikimaru F, Tomita K. Rikimaru F, et al. Gan To Kagaku Ryoho. 2007 Oct;34(10):1535-7. Gan To Kagaku Ryoho. 2007. PMID: 17940367 Review. Japanese.